These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparison of Bivalirudin Versus Heparin for Maintenance Systemic Anticoagulation During Adult and Pediatric Extracorporeal Membrane Oxygenation. Seelhammer TG; Bohman JK; Schulte PJ; Hanson AC; Aganga DO Crit Care Med; 2021 Sep; 49(9):1481-1492. PubMed ID: 33870916 [TBL] [Abstract][Full Text] [Related]
4. Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study. Pieri M; Agracheva N; Bonaveglio E; Greco T; De Bonis M; Covello RD; Zangrillo A; Pappalardo F J Cardiothorac Vasc Anesth; 2013 Feb; 27(1):30-4. PubMed ID: 23036625 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of Bivalirudin As an Alternative to Heparin for Systemic Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation. Hamzah M; Jarden AM; Ezetendu C; Stewart R Pediatr Crit Care Med; 2020 Sep; 21(9):827-834. PubMed ID: 32404633 [TBL] [Abstract][Full Text] [Related]
6. Prospective Exploratory Experience With Bivalirudin Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation. Ryerson LM; Balutis KR; Granoski DA; Nelson LR; Massicotte MP; Lequier LL; Bauman ME Pediatr Crit Care Med; 2020 Nov; 21(11):975-985. PubMed ID: 32976347 [TBL] [Abstract][Full Text] [Related]
7. Heparin-based versus bivalirudin-based anticoagulation in pediatric extracorporeal membrane oxygenation: A systematic review. Valdes CA; Sharaf OM; Bleiweis MS; Jacobs JP; Mumtaz M; Sharaf RM; Jeng EI; Peek GJ Front Med (Lausanne); 2023; 10():1137134. PubMed ID: 36999064 [TBL] [Abstract][Full Text] [Related]
8. Comparison of bleeding and thrombotic outcomes in veno-venous extracorporeal membrane oxygenation: Heparin versus bivalirudin. Kartika T; Mathews R; Migneco G; Bundy T; Kaempf AJ; Pfeffer M; DeLoughery TG; Moore K; Beardshear R; Oetken HJ; Case J; Hinds MT; McCarty OJT; Shatzel JJ; Zonies D; Zakhary B Eur J Haematol; 2024 Apr; 112(4):566-576. PubMed ID: 38088062 [TBL] [Abstract][Full Text] [Related]
9. Impact of anticoagulation strategy and agents on extracorporeal membrane oxygenation therapy. Macielak S; Burcham P; Whitson B; Abdel-Rasoul M; Rozycki A Perfusion; 2019 Nov; 34(8):671-678. PubMed ID: 31057056 [TBL] [Abstract][Full Text] [Related]
10. Comparison of bivalirudin versus heparin in adult extracorporeal membrane oxygenation anticoagulant therapy: A retrospective case-control study. Tong Y; Rouzhahong J; Zhou W; Wang R; Wang Y; Ren Y; Guo J; Li Y; Wang Z; Song Y Int J Artif Organs; 2023 Mar; 46(3):162-170. PubMed ID: 36600413 [TBL] [Abstract][Full Text] [Related]
11. Is anticoagulation with bivalirudin comparable to heparin for pediatric extracorporeal life support? Results from a high-volume center. Schill MR; Douds MT; Burns EL; Lahart MA; Said AS; Abarbanell AM Artif Organs; 2021 Jan; 45(1):15-21. PubMed ID: 32557733 [TBL] [Abstract][Full Text] [Related]
12. Bivalirudin in pediatric patients maintained on extracorporeal life support. Nagle EL; Dager WE; Duby JJ; Roberts AJ; Kenny LE; Murthy MS; Pretzlaff RK Pediatr Crit Care Med; 2013 May; 14(4):e182-8. PubMed ID: 23648880 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of Systemic Heparin Versus Bivalirudin in Adult Patients Supported by Extracorporeal Membrane Oxygenation. Berei TJ; Lillyblad MP; Wilson KJ; Garberich RF; Hryniewicz KM ASAIO J; 2018; 64(5):623-629. PubMed ID: 29076942 [TBL] [Abstract][Full Text] [Related]
14. Is bivalirudin an alternative anticoagulant for extracorporeal membrane oxygenation (ECMO) patients? A systematic review and meta-analysis. Li DH; Sun MW; Zhang JC; Zhang C; Deng L; Jiang H Thromb Res; 2022 Feb; 210():53-62. PubMed ID: 35007937 [TBL] [Abstract][Full Text] [Related]
15. Heparin vs bivalirudin anticoagulation for extracorporeal membrane oxygenation. Kaseer H; Soto-Arenall M; Sanghavi D; Moss J; Ratzlaff R; Pham S; Guru P J Card Surg; 2020 Apr; 35(4):779-786. PubMed ID: 32048330 [TBL] [Abstract][Full Text] [Related]
16. Argatroban for Anticoagulation in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation in Coronavirus Disease 2019. Sattler LA; Boster JM; Ivins-O'Keefe KM; Sobieszczyk MJ; Reel BA; Mason PE; Walter RJ; Sams VG Crit Care Explor; 2021 Sep; 3(9):e0530. PubMed ID: 34514426 [TBL] [Abstract][Full Text] [Related]
17. Superiority of bivalirudin over heparin anticoagulation therapy for extracorporeal membrane oxygenation? Too early to draw conclusions. Gu J; Yu H; Lin D Heliyon; 2023 Feb; 9(2):e13530. PubMed ID: 36865472 [TBL] [Abstract][Full Text] [Related]
18. Anticoagulation Strategies in Critically Ill Patients With SARS-CoV-2 Infection: The Role of Direct Thrombin Inhibitors. Pieri M; Quaggiotti L; Fominskiy E; Landoni G; CalabrĂ² MG; Ajello S; Bonizzoni MA; Belletti A; Scandroglio AM J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt B):2961-2967. PubMed ID: 35428549 [TBL] [Abstract][Full Text] [Related]
19. Management of Bivalirudin Anticoagulation Therapy for Extracorporeal Membrane Oxygenation in Heparin-Induced Thrombocytopenia: A Case Report and a Systematic Review. Zhong H; Zhu ML; Yu YT; Li W; Xing SP; Zhao XY; Wang WJ; Gu ZC; Gao Y Front Pharmacol; 2020; 11():565013. PubMed ID: 33013402 [TBL] [Abstract][Full Text] [Related]
20. Bivalirudin May Reduce the Need for Red Blood Cell Transfusion in Pediatric Cardiac Patients on Extracorporeal Membrane Oxygenation. Machado DS; Garvan C; Philip J; Harrington D; Spiess B; Kelly B; Campbell CT; Pelletier JPR; Islam S; Peek GJ; Bleiweis MS ASAIO J; 2021 Jun; 67(6):688-696. PubMed ID: 33031157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]